Effect of peritoneal dialysis on peritoneal cell biology: Peritoneal fibroblasts

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Jörres, Achim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell culture; Chemokines; Cytokines; Fibroblasts; Inflammation; Prostaglandins

Indexed keywords

CYTOKINE; PROSTAGLANDIN;

CONFERENCE PAPER; CYTOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PERITONEAL DIALYSIS; PERITONEUM CELL; PRIORITY JOURNAL;

CELLS, CULTURED; CHEMOKINES; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; PERITONEAL DIALYSIS; PERITONEUM; PROSTAGLANDINS;

EID: 1642602838     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Topley N, Brown Z, Jörres A, et al. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol. 1993; 142:1876-86.
2. Topley N, Jörres A, Luttmann W, et al. Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1 beta and TNF alpha. Kidney Int. 1993; 43:226-33.
3. Topley N, Petersen MM, Mackenzie RK, et al. Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int. 1994; 46:900-9.
4. Topley N, Williams JD. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int. 1994; 46(Suppl 48):S71-8.
5. Witowski J, Jörres A, Coles GA, Williams JD, Topley N. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA. Kidney Int. 1996; 50:1212-23.
6. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int. 1992; 12:14-27.
7. Pollock CA, Ibels LS, Eckstein RP, et al. Peritoneal morphology on maintenance dialysis. Am J Nephrol. 1989; 9:198-204.
8. Verger C, Brunschvicg O, Le Charpentier Y, Lavergne A, Vantelon J. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc. 1981; 18:199-205.
9. Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif. 1989; 7:74-85.
10. Dobbie JW, Lloyd JK, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:3-12.
11. Van Bronswijk H, Verbrugh HA, Bos HJ, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int. 1989; 9:197-202.
12. Liberek T, Topley N, Mistry CD, et al. Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit Dial Int. 1993; 13:104-11.
13. Topley N, Mackenzie RK, Petersen MM, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant. 1991; 6:574-81.
14. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int. 1995; 47:282-93.
15. Topley N, Kaur D, Petersen MM, et al. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol. 1996; 7:218-24.
16. Topley N, Kaur D, Petersen MM, et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: Influence on mesothelial cell and neutrophil function. Kidney Int. 1996; 49:1447-56.
17. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol. 1994; 1:229-46.
18. Lukacs NW, Kunkel SL, Allen R, et al. Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. Am J Physiol. 1995; 268:L856-61.
19. Schröder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E. IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol. 1990; 144:2223-32.
20. Mielke V, Bauman JG, Sticherling M, et al. Detection of neutrophil-activating peptide NAP/IL-8 and NAP/ IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study. J Immunol. 1990; 144:153-61.
21. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology. 1989; 68:31-6.
22. Larsen CG, Zachariae CO, Oppenheim JJ, Matsushima K. Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor. Biochem Biophys Res Commun. 1989; 160:1403-8.
23. Rolfe MW, Kunkel SL, Standiford TJ, et al. Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am J Physiol. 1992; 263:L536-45.
24. May LT, Santhanam U, Sehgal PB. On the multimeric nature of natural human interleukin-6. J Biol Chem. 1991; 266:9950-5.
25. Elias JA, Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol. 1990; 145: 161-6.
26. Elias JA, Reynolds MM, Kotloff RM, Kern JA. Fibroblast interleukin 1 beta: Synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation. Proc Natl Acad Sci USA. 1989; 86:6171-5.
27. Krzesicki RF, Hatfield CA, Bienkowski MJ, et al. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol. 1993; 150:4008-18.
28. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985; 162:2163-8.
29. Elias JA, Gustilo K, Baeder W, Freundlich B. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol. 1987; 138:3812-16.
30. Hori T, Yamanaka Y, Hayakawa M, et al. Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. Biochem Biophys Res Commun. 1991; 174:758-66.
31. Raz A, Wyche A, Fagan D, Needleman P. The cell biology of fibroblast cyclooxygenase. Adv Exp Med Biol. 1989; 259:1-21.
32. Diaz A, Munoz E, Johnston R, Korn JH, Jimenez SA. Regulation of human lung fibroblast alpha 1(1) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem. 1993; 268:10364-71.
33. Scharffetter K, Heckmann M, Hatamochi A, et al. Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res. 1989; 181:409-19.
34. Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol. 1991; 97:686-92.
35. 2, and proliferation in human fibroblasts. Exp Cell Res. 1994; 210:166-71.
36. Smith TJ, Higgins PJ. Interferon gamma regulation of de novo protein synthesis in human dermal fibroblasts in culture is anatomic site dependent. J Invest Dermatol. 1993; 100:288-92.
37. Jörres A, Ludat K, Lang J, et al. Establishment and functional characterization of human peritoneal fibroblasts in culture: Regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol. 1996; 7:2192-201.
38. Jörres A, Ludat K, Sander K, et al. The peritoneal fibroblast and the control of peritoneal inflammation. Kidney Int. 1996; 50(Suppl 56):S22-7.
39. Ludat K, Jörres A, Dunkel K, et al. Human peritoneal fibroblast prostaglandin synthesis: Induction of cyclooxygenase (cox-1 and cox-2) mRNA by peritoneal macrophage-derived cytokines [Abstract]. Nephrol Dial Transplant. 1995; 10:1042.
40. Witowski J, Thiel A, Fröhlich S, Gahl GM, Frei U, Jörres A. Monocyte-chemoattractant protein-1 expression and synthesis in human peritoneal fibroblasts: Induction by IL-1β and TNFα [Abstract]. Perit Int Dial. 1998; 18(Suppl 1):S35.
41. Witowski J, Thiel A, Fröhlich S, Gahl GM, Frei U, Jörres A. Expression and synthesis of the C-C chemokine RANTES in human peritoneal fibroblasts [Abstract]. Perit Dial Int. 1998; 18:115
42. Witowski J, Thiel A, Fröhlich S, Gahl GM, Frei U, Jörres A. Expression and synthesis of C-X-C chemokines in human peritoneal fibroblasts (HPFB); induction by IL-1b and TNFα [Abstract]. J Am Soc Nephrol. 1998; 9:292A.
43. Jörres A, Finn A, Bender TO, Gahl GM, Frei U, Passlick-Deetjen J. Effect of peritoneal dialysis fluids on cytokine release by human peritoneal fibroblasts in culture [Abstract]. XIVth Int Congress of Nephrology, May 25-29, 1997, Sydney, Australia.
44. Jörres A, Bender TO, Finn A, et al. Biocompatibility and buffers: Effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int. 1998; 54:2184-93.
45. Mauch C, Adelmann-Grill B, Hatamochi A, Krieg T. Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett. 1989; 250:301-5.
46. Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int. 1997; 51: 205-15.